Safely navigating through a crisis

2020 will go down as one of the most difficult for companies and leaders around the world.  The corona virus has taken lives, isolated families, closed airports and put a fear into many like never before.  Whilst most of us have had the privilege of a stable life occupied with routine, the future is now...
Latest News Today, Melbourne based Medtech company, Optalert Australia, were announced as the recipient of the Australian Government – Automotive Innovation Lab Access Grant (AILAG).   The grant will be used to advance the development of the Optalert Video Automotive technology solution for the objective, early prediction of drowsiness and attentiveness monitoring. The project aims to...
Connecting the physical world with the digital world Industry 4.0 fundamentally changes the way in which businesses create and capture value. This shift is enabled by a set of technologies including autonomous robots, simulation technology, system integration, the Internet of Things (IoT), cybersecurity, cloud computing, additive manufacturing, augmented reality and big data. Industry 4.0 technologies...
The National Transport Commission (NTC) and the Cooperative Research Centre for Alertness, Safety and Productivity (Alertness CRC) today released the results of a world-first study into heavy vehicle driver fatigue. The two-year scientific study evaluated alertness monitoring technology and the impacts of work shifts on driver alertness. It analysed shift start time, the number of...
The Consumer Electronics Show (CES2019) dazzled participants once again with glimpses of technologies and products on the horizon for the future.  With over 180,000 attendees from 150 different countries, circulating over 11 venues throughout Las Vegas. Optalert’s key conversations at this year’s event included autonomous vehicles, enhanced ‘early warning’ drowsiness and distraction features, and AI...
Pharmaceutical companies face many challenges, with hundreds of new drugs required to transition through clinical trial phases, regulatory processes and to market, more quickly and more efficiently. The Centre for the Study of Drug Development (CSDD) estimates the cost of developing a prescription drug that gains market approval at $2.6 billion. Even more remarkable is...

Search

Categories

Categories

Date

Date

Search

Categories

Categories

Date

Date